Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach

Area of Science:

• Immunology
• Regenerative Medicine
• Cell Therapy

Background:

• Mesenchymal Stem Cells (MSCs) exhibit immunomodulatory and regenerative potential, necessitating reliable potency assays for clinical applications.
• Characterizing the complex immune interactions of MSCs requires a multifaceted approach to capture their effector pathways.

Purpose of the Study:

• To identify and validate assay systems for characterizing the immune potency of human Mesenchymal Stem Cells (MSCs).
• To establish a simplified platform for robust potency analysis of MSCs for advanced clinical trials.

Main Methods:

• Evaluation of two distinct assay systems: MSC secretome analysis and a quantitative RNA-based array.
• Analysis of gene expression specific to immunomodulatory and homing properties of MSCs.
• Utilized interferon-gamma (IFN-γ) as a surrogate for activated peripheral blood mononuclear cells (PBMCs) to assess MSC responses.

Main Results:

• Secretome analysis revealed a unique cytokine signature associated with MSC-mediated T-cell suppression.
• The RNA-based array provided insights into genes critical for MSC immunomodulation and homing.
• Interferon-gamma stimulation offered a viable alternative to using human PBMCs as responder cells in potency assays.

Conclusions:

• The developed assay matrix approach simplifies the characterization of MSC multifunctional responses.
• This platform provides a robust method for potency analysis, crucial for advancing MSC-based therapies in clinical settings.